Cargando…

Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials

INTRODUCTION: Delirium, being a common disorder among critically ill patients, has a reported incidence ranging 45–83% in the intensive care unit (ICU) population. The prophylactic use of melatonin and melatonergics has been shown to have a positive effect in reducing the incidence of delirium in ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukundarajan, Ramkumar, Soni, Kapil Dev, Trikha, Anjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504656/
https://www.ncbi.nlm.nih.gov/pubmed/37719343
http://dx.doi.org/10.5005/jp-journals-10071-24529
_version_ 1785106772974895104
author Mukundarajan, Ramkumar
Soni, Kapil Dev
Trikha, Anjan
author_facet Mukundarajan, Ramkumar
Soni, Kapil Dev
Trikha, Anjan
author_sort Mukundarajan, Ramkumar
collection PubMed
description INTRODUCTION: Delirium, being a common disorder among critically ill patients, has a reported incidence ranging 45–83% in the intensive care unit (ICU) population. The prophylactic use of melatonin and melatonergics has been shown to have a positive effect in reducing the incidence of delirium in many clinical trials. Our study was thus proposed to find out the role of melatonin on the incidence and severity of ICU delirium, ICU and hospital length of stay (LOS), requirement, duration of mechanical ventilation, and ICU mortality. METHODOLOGY: A systematic search of various databases was performed to find out the trials which compare melatonin with a placebo or standard therapy for delirium prevention with the results conveyed as mean differences (MDs) or risk ratios. The statistical software, Review Manager (RevMan, version 5.4), was used for data synthesis. RESULTS: Twelve studies were included in the meta-analysis. Prophylactic administration of melatonin or ramelteon was not associated with a statistically significant reduction in the incidence of delirium (odds ratio [OR] 0.63; confidence interval [CI]: 0.60, 1.32; p = 0.22), the severity of delirium (MD: 0.22; 95% CI: From −1.36 to 1.81; p = 0.78), ICU LOS (MD: 0.05; 95% CI: From −0.65 to 0.75; p = 0.89), hospital LOS (MD: −1.46; 95% CI: From −4.50 to −1.59; p = 0.35), need for mechanical ventilation (OR: 0.74, 95% CI: 0.38−1.44; p = 0.37), and ICU mortality (MD: 0.78; 95% CI: 0.56; 1.11; p = 0.62). However, a significant reduction in the duration of mechanical ventilation (MD: −0.85; 95% CI: From −1.64 to −0.06; p = 0.03) was found. CONCLUSION: Our meta-analysis suggests that melatonin when given prophylactically has no significant role in reducing the incidence and severity of delirium, ICU and hospital LOS, need for mechanical ventilation, duration of mechanical ventilation, and ICU mortality. Further studies are warranted. HOW TO CITE THIS ARTICLE: Mukundarajan R, Soni KD, Trikha A. Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials. Indian J Crit Care Med 2023;27(9):675–685.
format Online
Article
Text
id pubmed-10504656
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-105046562023-09-17 Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials Mukundarajan, Ramkumar Soni, Kapil Dev Trikha, Anjan Indian J Crit Care Med Review Article INTRODUCTION: Delirium, being a common disorder among critically ill patients, has a reported incidence ranging 45–83% in the intensive care unit (ICU) population. The prophylactic use of melatonin and melatonergics has been shown to have a positive effect in reducing the incidence of delirium in many clinical trials. Our study was thus proposed to find out the role of melatonin on the incidence and severity of ICU delirium, ICU and hospital length of stay (LOS), requirement, duration of mechanical ventilation, and ICU mortality. METHODOLOGY: A systematic search of various databases was performed to find out the trials which compare melatonin with a placebo or standard therapy for delirium prevention with the results conveyed as mean differences (MDs) or risk ratios. The statistical software, Review Manager (RevMan, version 5.4), was used for data synthesis. RESULTS: Twelve studies were included in the meta-analysis. Prophylactic administration of melatonin or ramelteon was not associated with a statistically significant reduction in the incidence of delirium (odds ratio [OR] 0.63; confidence interval [CI]: 0.60, 1.32; p = 0.22), the severity of delirium (MD: 0.22; 95% CI: From −1.36 to 1.81; p = 0.78), ICU LOS (MD: 0.05; 95% CI: From −0.65 to 0.75; p = 0.89), hospital LOS (MD: −1.46; 95% CI: From −4.50 to −1.59; p = 0.35), need for mechanical ventilation (OR: 0.74, 95% CI: 0.38−1.44; p = 0.37), and ICU mortality (MD: 0.78; 95% CI: 0.56; 1.11; p = 0.62). However, a significant reduction in the duration of mechanical ventilation (MD: −0.85; 95% CI: From −1.64 to −0.06; p = 0.03) was found. CONCLUSION: Our meta-analysis suggests that melatonin when given prophylactically has no significant role in reducing the incidence and severity of delirium, ICU and hospital LOS, need for mechanical ventilation, duration of mechanical ventilation, and ICU mortality. Further studies are warranted. HOW TO CITE THIS ARTICLE: Mukundarajan R, Soni KD, Trikha A. Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials. Indian J Crit Care Med 2023;27(9):675–685. Jaypee Brothers Medical Publishers 2023-09 /pmc/articles/PMC10504656/ /pubmed/37719343 http://dx.doi.org/10.5005/jp-journals-10071-24529 Text en Copyright © 2023; The Author(s). https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2023 Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review Article
Mukundarajan, Ramkumar
Soni, Kapil Dev
Trikha, Anjan
Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
title Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
title_full Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
title_fullStr Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
title_full_unstemmed Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
title_short Prophylactic Melatonin for Delirium in Intensive Care Unit: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials
title_sort prophylactic melatonin for delirium in intensive care unit: an updated systematic review and meta-analysis of randomized controlled trials
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504656/
https://www.ncbi.nlm.nih.gov/pubmed/37719343
http://dx.doi.org/10.5005/jp-journals-10071-24529
work_keys_str_mv AT mukundarajanramkumar prophylacticmelatoninfordeliriuminintensivecareunitanupdatedsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT sonikapildev prophylacticmelatoninfordeliriuminintensivecareunitanupdatedsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT trikhaanjan prophylacticmelatoninfordeliriuminintensivecareunitanupdatedsystematicreviewandmetaanalysisofrandomizedcontrolledtrials